LegitScript certified · 4.6 on Trustpilot · HIPAA compliant · US-licensed compounding pharmacy
Back to Recovery Peptides
BPC-157 vial
Recovery Peptides

BPC-157

Body Protection Compound-157

Provider-guided peptide therapy that may be considered for eligible patients as part of a personalized recovery plan. Whether BPC-157 is appropriate for you is determined during a licensed-provider evaluation; outcomes are individual and not guaranteed.

From $160/mo

Monthly (Cancel Anytime)  |  3-Month & 6-Month Bundles Available

Frequency

As Prescribed

Rx Required

Yes — Prescribed Online

Pharmacy

US-Registered

Shipping

Free & Discreet

How BPC-157 Works

BPC-157 (Body Protection Compound-157) is a synthetic peptide of 15 amino acids derived from a protein naturally present in gastric juice. It has been the subject of decades of preclinical research exploring how it interacts with cellular signaling pathways.

In preclinical models, researchers have examined BPC-157's activity on cellular signaling pathways, including angiogenesis (the formation of new blood vessels), fibroblast migration, and growth factor expression. Research has also studied its activity in interactions with growth hormone receptors. Clinical applicability in humans is a determination made by a licensed provider during evaluation.

These findings come primarily from animal and preclinical research. Human clinical data is accumulating, and BPC-157 is not FDA-approved as a finished drug. Whether it is appropriate for you is a clinical determination made by a licensed provider during evaluation; individual results vary.

What BPC-157 Can Do for You

Provider-Guided Wellness Plans

May be considered as part of a personalized wellness plan when prescribed by a licensed provider after evaluation of your medical history and goals.

Gastrointestinal Wellness Discussion

Discussed with your provider during evaluation. Specific gastrointestinal concerns require a separate medical assessment and are not a guaranteed outcome.

Cellular Signaling Research

Studied in preclinical research for activity on cellular signaling pathways. Clinical relevance is determined by your provider during evaluation.

Provider-Discussed Wellness Goals

Studied in preclinical research for potential joint support. Discussed during your provider evaluation for any relevant personal goals.

Nerve Biology Research

Studied in preclinical research for activity in models of nerve biology. Whether BPC-157 is appropriate for an individual is determined by a licensed provider during evaluation; outcomes vary.

Personalized Post-Procedure Plans

Eligible patients can discuss BPC-157 with a licensed provider, who determines suitability based on individual medical history and wellness goals.

What to Expect

1

Week 1–2: Activation Phase

Your provider prescribes a personalized BPC-157 protocol. Your personalized regimen begins under your provider's guidance.

2

Week 2-4: Plan Adherence

Many patients meet with their provider to review progress and adjust their regimen as needed.

3

Week 4-8+: Ongoing Provider Follow-Up

Patients continue working with their provider to evaluate response and refine the plan based on individual goals.

Compounding Notice

BPC-157 is a compounded medication that is not approved by the U.S. Food and Drug Administration (FDA). It is prepared by a U.S.-registered compounding pharmacy for individual patients based on a valid prescription, and is classified by the FDA as a bulk drug substance under section 503A of the Federal Food, Drug, and Cosmetic Act. Use only under the ongoing supervision of a licensed healthcare provider. Learn more about compounded medications under section 503A.

Important Safety Information

BPC-157 is not FDA-approved. It is compounded by a US-registered pharmacy under physician supervision. Side effects are generally rare and mild, and may include minor injection site irritation or temporary dizziness. BPC-157 has been studied for over 30 years with a strong safety profile in research settings.

This product is not intended to diagnose, treat, cure, or prevent any disease. All treatment protocols are determined by licensed medical providers based on your individual health profile. Consult your healthcare provider before starting any new treatment.

See if peptide therapy fits your goals

Complete a brief online evaluation to see if BPC-157 peptide therapy is appropriate for you. A licensed provider determines eligibility and creates your personalized plan.

BPC-157 questions, answered

BPC-157 is a synthetic peptide derived from a protein found in human gastric juice. It has been studied in preclinical research for its role in cellular signaling related to recovery and connective-tissue biology. Through Madison Meds, eligible patients can access compounded BPC-157 starting at $160/month after a licensed provider evaluation.
BPC-157 is discussed with eligible patients during a licensed-provider evaluation as part of a personalized wellness plan. Specific applications are determined by the provider based on your history and goals; outcomes vary.
In preclinical research, BPC-157 has been studied for its activity on cellular signaling pathways, including angiogenesis (new blood vessel formation) and growth factor expression. Whether BPC-157 is appropriate for an individual is a clinical determination made by a licensed provider during evaluation; outcomes are individual and not guaranteed.
Common protocols use 250-500 mcg daily as a subcutaneous injection in the abdomen, with frequency and duration personalized by the prescribing provider during evaluation. Cycle length varies by individual plan.
Patient-reported timelines vary considerably. Your provider will set realistic expectations based on your individual plan; outcomes vary and are not guaranteed.
BPC-157 has shown a favorable safety profile in animal research and anecdotal human use, with side effects rare and typically mild (mild fatigue, injection-site irritation). However, large-scale human clinical trials are limited. Madison Meds providers review your medical history before prescribing to ensure it's appropriate for you.
BPC-157 is not FDA-approved as a finished medication but can be prescribed and compounded by US-licensed pharmacies under section 503A. The FDA placed BPC-157 on a restricted Category 2 list in 2023, though it remains accessible through accredited compounding pharmacies with valid prescriptions, like those Madison Meds partners with.
Subcutaneous injection is the most studied and commonly used route in available research. Oral BPC-157 has lower systemic bioavailability. Through Madison Meds, providers most often prescribe injectable forms based on the available evidence; the appropriate route is set during a licensed-provider evaluation.
Stacking with other peptides may be considered as part of a provider-guided plan. Madison Meds offers GLOW and Wolverine combinations through partner pharmacies; eligibility and stacking decisions are made by the prescribing provider.
Through Madison Meds, BPC-157 is available starting at $160/month after a licensed provider evaluation, with the medication dispensed by a US-licensed compounding pharmacy. Pricing is bundled to include the provider consultation, medication, and free discreet shipping. This is significantly less than concierge clinics that often charge $300–$500+ per vial.